drugset / Trial / NCT00000209

Buprenorphine Dosing Interval - 5

NCT00000209

Single-blindTreatment

Summary

The purpose of this study is to explore the feasibility of extending the dosing interval of well maintained buprenorphine patients to 48 and 72 hours, leading to eventual 3 times/week dosing.

Timeline

Start
1992-11
Primary completion
Completion

Publications

  • Background 1) Buprenorphine as a pharmacotherapy for opiate addiction. What dose provides a therapeutic response? (An J Add 1996; 5(3): 220-222). (1) Buprenorphine as a pharmacotherapy for opiate addiction. What dose provides a therapeutic response? (An J Add 1996; 5(3):220-222).

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified